News from Boston Scientific A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 16, 2016, 16:30 ET Boston Scientific To Participate In Piper Jaffray 2016 Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 28th Annual Piper Jaffray Healthcare Conference on November 29 in New...


Nov 16, 2016, 13:34 ET Boston Scientific Announces Positive Results Of HeartLogic™ Heart Failure Diagnostic Service

Boston Scientific (NYSE: BSX) today announced results from the first clinical trial evaluating the performance of the HeartLogic™ Heart Failure...


Nov 02, 2016, 09:43 ET Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN™ Left Atrial Appendage Closure Device

Boston Scientific (NYSE: BSX) announced initial U.S. commercial performance results of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device...


Oct 24, 2016, 16:30 ET Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2016

Boston Scientific (NYSE: BSX) today announced key data which will be presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the...


May 03, 2016, 16:33 ET Boston Scientific Announces U.S. FDA Approval of Navigation-Enabled Ablation Catheters

 Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with the...


Apr 25, 2016, 16:30 ET Boston Scientific Receives U.S. FDA Approval For ImageReady™ MR-Conditional Pacing System

Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for a suite of products deemed safe for use in a...


Dec 09, 2015, 16:30 ET Voluntary Recall of Chariot™ Guiding Sheath

 Boston Scientific (NYSE: BSX) has voluntarily recalled the Chariot™ Guiding Sheath globally. These devices are intended for the...


Nov 30, 2015, 16:15 ET Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

Boston Scientific (NYSE: BSX) has received United States (U.S.) Food and Drug Administration (FDA) approval and CE Mark for the AngioJet™...


Nov 19, 2015, 16:30 ET Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Boston Scientific (NYSE: BSX) today announced that the first implants of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device...


Nov 17, 2015, 08:30 ET Boston Scientific To Participate In Piper Jaffray 2015 Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray 27th Annual Healthcare Conference on December 1, in New...


Nov 10, 2015, 08:30 ET Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences

Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a...


Oct 07, 2015, 17:00 ET Boston Scientific Launches Online Competition For New Digital Health Technologies

Boston Scientific (NYSE: BSX) this week announced the start of the Boston Scientific Connected Patient Challenge, an open innovation contest...


Oct 05, 2015, 06:30 ET Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

 Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer...


Dec 12, 2014, 09:00 ET New Data Presented At NANS 2014 Demonstrate Long-Term, Low Back Pain Relief With Boston Scientific Precision Spectra™ Spinal Cord Stimulator System

New retrospective data evaluating the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System...


Nov 19, 2014, 12:10 ET New Data From Evolve Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

In the first successful U.S. pivotal trial of a bioabsorbable polymer stent, the Boston Scientific (NYSE: BSX) SYNERGY™ Everolimus-Eluting...


Sep 15, 2014, 16:05 ET REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

New data from the Boston Scientific (NYSE: BSX) clinical trial program of the Lotus™ Valve System continue to demonstrate strong performance...


Jun 09, 2014, 02:00 ET Boston Scientific Bietet an seinem "Institute for Advancing Science" in Paris eine Endoskopie-Ausbildung der Weltklasse an

Boston Scientific unterstreicht damit seinen Einsatz für globale Weiterbildung und Innovation  PARIS, 15.Mai 2014 - Boston Scientific...


Jun 06, 2014, 09:00 ET Boston Scientific ofrece formación puntera a endoscopistas en las nuevas instalaciones de su Paris Institute

Boston Scientific Corporation (NYSE:BSX) ha celebrado la inauguración de unas nuevas instalaciones dedicadas a la formación en la...


Jun 05, 2014, 03:00 ET Boston Scientific propose en endoscopie des formations d'excellence dans son institut de formation de Paris (Institute for Advancing Science - IAS)

Boston Scientific renforce à l'échelle mondiale son engagement en termes de formation et d'innovation  Boston Scientific...


Jun 03, 2014, 04:19 ET Boston Scientific ofrece formación puntera a endoscopistas en las nuevas instalaciones de su Paris Institute

Boston Scientific refuerza su compromiso con la formación y la innovación a escala mundial  Boston Scientific Corporation...


Jun 03, 2014, 04:18 ET Boston Scientific offre una formazione di prim'ordine in ambito endoscopico presso l'Institute for Advancing Science di Parigi

Boston Scientific rafforza il suo impegno nell'educazione e nell'innovazione a livello globale  Boston Scientific Corporation (NYSE:BSX) ha...


Jun 02, 2014, 03:00 ET La valve Lotus™ de Boston Scientific demontre un excellent profil de performance et de securite a 6 mois de suivi

  Une régurgitation paravalvulaire aortique modérée rapportée chez 1.1% des patients uniquement Aucun cas de...


May 27, 2014, 04:31 ET Aortenklappensystem Lotus™ von Boston Scientific demonstriert starkes Leistungs- und Sicherheitsprofil über 6 Monate

Nur bei 1,1% der Patienten kommt es zu mäßiggradiger paravalvulärer Regurgitation; schwere Fälle traten nicht auf   Im...


May 27, 2014, 04:15 ET Boston Scientific anuncia datos que sugieren el alto rendimiento del stent SYNERGY™

Los datos del estudio EVOLVE, presentados hoy en EuroPCR 2014, muestran además un excelente perfil de seguridad. Boston Scientific...


May 27, 2014, 04:11 ET La válvula Lotus™ de Boston Scientific confirma su rendimiento y seguridad al cabo de seis meses

Solo un 1,1% de los pacientes sufrió regurgitación paravalvular aórtica moderada; no se produjo ningún caso grave...